Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 56672-63-0 | MDL No. : | MFCD00038946 |
Formula : | C14H21ClN4O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HHCPMSWPCALFQJ-MERQFXBCSA-N |
M.W : | 344.79 | Pubchem ID : | 13104814 |
Synonyms : |
|
Num. heavy atoms : | 23 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 11 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 5.0 |
Molar Refractivity : | 87.37 |
TPSA : | 137.53 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.4 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.41 |
Log Po/w (WLOGP) : | 1.28 |
Log Po/w (MLOGP) : | 0.96 |
Log Po/w (SILICOS-IT) : | 0.09 |
Consensus Log Po/w : | 0.75 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 1.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.33 |
Solubility : | 1.6 mg/ml ; 0.00464 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.9 |
Solubility : | 0.0432 mg/ml ; 0.000125 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.95 |
Solubility : | 0.386 mg/ml ; 0.00112 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.15 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H317-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.985 g | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 20℃; for 4.0h; | Cbz-Arg-OH (3.448 g, 10 mmol), HOBT (1.531 g, 10 mmol), 4-aminobenzylalcohol (1.232 g, 10 mmol) and EDCl (2.300 g, 10 mmol) was dissolved in 50 mL DMF. 4.0 hour later, the solvent DMF was removed by high vacuum. The residue was separated by column chromatography 120 g silica gel (gradient: methanol/dichloromethane 5% to 34%), then solvent was removed by rotavap and got 3.985 g light brown solid. 1H NMR (500 MHz, DMSO) delta 10.20 (s, 1H), 7.87 (t, J=5.4 Hz, 1H), 7.61 (dd, J=14.4, 8.1 Hz, 3H), 7.39-7.29 (m, 5H), 7.24 (d, J=8.4 Hz, 2H), 5.14 (t, J=5.7 Hz, 1H), 5.08-4.95 (m, 2H), 4.43 (d, J=5.6 Hz, 2H), 4.19 (dd, J=13.7, 8.3 Hz, 1H), 3.12 (dd, J=12.8, 6.5 Hz, 2H), 1.84-1.70 (m, 1H), 1.69-1.41 (m, 3H). 13C NMR (126 MHz, DMSO) delta 170.65, 156.92, 156.03, 137.54, 137.46, 136.96, 128.35, 127.80, 127.71, 126.85, 118.97, 65.46, 62.57, 54.92, 40.13, 28.94, 25.21. HRMS (ESI) calcd for C21H28N5O4+ (MH+) 414.2136. found 414.2149. |